Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity

XianTian Zhang(CHI Health Creighton University Medical Center - Bergan Mercy), Zhaoyi Wang(CHI Health Creighton University Medical Center - Bergan Mercy)
Endocrinology
April 1, 2013
10.1210/en.2013-1116
Cited by 54

Related Papers

Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
|PLoS ONE|2012|71
ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
|PLoS ONE|2014|67
Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
|PLoS ONE|2014|42
Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells
|Oncology Reports|2012|39
A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells
|PLoS ONE|2012|20